USE OF MODIFIED CYCLOSPORINS FOR THE TREATMENT OF HCV DISORDERS

摘要

Disclosed are non-immunosuppressive cyclophilin-binding cyclosporins, e.g. of formula (I, Ia or II) as defined herein, having useful properties in the prevention or treatment of Hepatitis C infections.